Why IMU is a multi multi bagger, page-16828

" this revolves around the research and licensing arrangements with City of Hope and Prof Fong for example and the relationships that exist. Those agreements might have trigger clauses around retaining key staff and so on in order to protect what the IP is achieving."

Odds&Evens, agree, Professor Fong, Associate Professor Priceman and the City of Hope are currently controlling the future direction for CF33 and onCARlytics in partnership with IMUGENE.
IMO, as soon as there is a substantial data publication on the above trials or a Big Pharma partnership or licence agreement is announced, then that would enable Imugene 2.0 to be formed and listed on the NasdaqCM. The remaining drug development platforms for Imugene 1.0 would remain trading on the ASX.

Regards.